Enis C Yilmaz, Yue Lin, Mason J Belue, Stephanie A Harmon, Tim E Phelps, Katie M Merriman, Lindsey A Hazen, Charisse Garcia, Latrice Johnson, Nathan S Lay, Antoun Toubaji, Maria J Merino, Krishnan R Patel, Howard L Parnes, Yan Mee Law, Bradford J Wood, Sandeep Gurram, Peter L Choyke, Peter A Pinto, Baris Turkbey
Background: Precise risk stratification through MRI/US fusion-guided targeted biopsy (TBx) can guide optimal prostate cancer (PCa) management. Objective: The purpose of this study was to compare PI-RADS version 2.0 (v2.0) and PI-RADS version 2.1 (v2.1) in terms of the rates of International Society of Urological Pathology (ISUP) grade group (GG) upgrade and down grade from TBx to radical prostatectomy (RP). Methods: This study entailed a retrospective post-hoc analysis of patients who underwent 3-T prostate MRI at a single institution from May 2015 to March 2023 as part of prospective clinical trials...
September 20, 2023: AJR. American Journal of Roentgenology